The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Gagan Harsh Sharma & PACs
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bliss GVS Pharma has informed the exchanges about a disclosure filed under Regulation 29(1) of the SEBI Takeover Regulations. The disclosure was made by Gagan Harsh Sharma along with Persons Acting in Concert (PACs), indicating a change in their shareholding that crossed the SEBI-prescribed reporting threshold. Regulation 29(1) requires reporting when any acquirer's holding crosses 5% or changes by 2% or more from the last disclosure. The exact direction of the transaction (acquisition or disposal), the percentage change, and the resulting shareholding figure are not mentioned in the available filing text. Investors should wait for the detailed disclosure to understand whether this is a promoter group buying or selling.
A SAST disclosure by a promoter-group member often signals a meaningful shift in ownership and can influence short-term stock sentiment, but the actual price impact depends on whether shares were bought or sold and at what level.